These findings suggest that blocking the SIRPα-CD47 axis modestly alleviates metabolic disorders in ob/ob mice, partly by reducing vWAT-Exos carrying pro-lipid accumulation signals. The gene discussed is SIRPA; the disease is metabolic disease.